December 24, 2025
The smart healthcare market is expected to rise from USD 397.98 billion in 2026 to USD 1833.7 billion by 2035,...
Read MoreNovember 13, 2025
The blood pressure measuring devices market is expected to see growth from USD 2.08 billion in 2026 to USD 4.5...
Read MoreJanuary 19, 2026
The U.S. digital health market size is forecast to increase from USD 98.69 billion in 2026 to USD 266.5 billio...
Read MoreDecember 29, 2025
The cardiometabolic diseases market size is anticipated to grow from USD 292.04 billion in 2026 to USD 1987.69...
Read MoreDecember 29, 2025
Based on market forecasts, the global fondaparinux market, projected at USD 721 million in 2025, is expected to reach USD 1419.61 million by 2035, growing at a CAGR of 6.36% over the forecast period. The increasing number of surgeries and growing research activities drive the global market. North America dominated the global market owing to the pre...
December 29, 2025
Market insights predict the global sciatica treatment industry will increase from USD 796 million in 2025 to USD 1171.76 million by 2035, achieving a CAGR of 3.94%. The market is driven by sedentary lifestyles and aging populations, fuel demand for effective pain management solutions. North America is leading the global market, driven by robust hea...
December 29, 2025
According to market projections, the cardiometabolic diseases market was valued at USD 292.04 billion in 2026 and is projected to reach approximately USD 1,987.69 billion by 2035, growing at a strong CAGR of 23.75% from 2026 to 2035. The cardiometabolic diseases market analysis covers detailed segment data by disease type, therapeutic class, treatm...
December 29, 2025
The GLP-1 small molecule market covers comprehensive insights on global market size, segmentation, regional performance, and competitive dynamics across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The market accounted for nearly 40% revenue share in North America in 2025, while Asia Pacific is projected to ...
December 26, 2025
Based on market forecasts, the alzheimer’s therapeutics sector will expand from USD 5.7 billion in 2025 to USD 13.13 billion by 2035, experiencing a CAGR of 8.7%. In 2024, North America led the market, while Asia-Pacific is set for the fastest growth ahead. Cholinesterase inhibitors dominated by product, but pipeline drugs are expected to gro...
December 26, 2025
The gene-editing therapeutics market is expanding due to growing advancements in gene editing technologies as well as their increasing applications. North America led the market due to the presence of the largest cluster of sponsors. ...
December 26, 2025
According to market projections, the global septicemia antibiotics market, valued at USD 2.7 billion in 2025, is anticipated to reach USD 3.61 billion by 2035, growing at a CAGR of 2.94% over the next decade. The rising prevalence of sepsis and the increasing antimicrobial resistance drive the global market. A robust healthcare infrastructure and f...
December 24, 2025
According to forecasts, the global Cell-Based Immunotherapies market will grow from USD 4.59 billion in 2024 to USD 18.62 billion by 2034, with an expected CAGR of 15.02%. The cell-based immunotherapies market is growing due to rising cancer incidence and increasing for personalized, targeted treatment approaches. Advanced in cell engineering and r...
December 24, 2025
The Market is expanding rapidly as breakthroughs in genetic engineering and precision medicine unlock effective treatments for previously untreatable cancers. Investment in universal CAR-T platforms, combination strategies with checkpoint inhibitors, and a strong clinical pipeline is accelerating innovation and broadening adoption....
December 24, 2025
According to market projections, the U.S. human fibrinogen concentrates market, valued at USD 172.95 million in 2025, is anticipated to reach USD 714.42 million by 2035, growing at a CAGR of 15.24% over the next decade.The importance of human fibrinogen concentrates is raised due to congenital fibrinogen deficiency or acquired fibrinogen deficiency...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com